Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors
Abstract Oraxol consists of an oral dosage form of the chemotherapeutic agent paclitaxel administered with a novel P‐glycoprotein inhibitor encequidar methanesulfonate monohydrate (formerly named HM30181A), which allows oral treatment of cancers that would otherwise be treated with intravenous pacli...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2022-07-01
|
| Seri Bilgileri: | CPT: Pharmacometrics & Systems Pharmacology |
| Online Erişim: | https://doi.org/10.1002/psp4.12799 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|